BioCentury | Feb 25, 2021
Finance

$135M series C buys Vividion flexibility to explore broad pipeline

...Woodline Partners, Acuta Capital and Driehaus Capital Management, alongside existing investors BVF Partners, Casdin Capital, Mubadala...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...private placement in which it sold shares to Mubadala Investment Co. and Novo Holdings A/S. Mubadala...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...has raised $7.9 million in a seed round led by Horizons Ventures, with participation from Mubadala...
BioCentury | Jun 17, 2020
Emerging Company Profile

Lightspeed, Klausner back Stanford cell therapy spinout Orca in new $192M round

...investor also co-led the round. Other series D investors included 8VC, DCVC Bio, ND Capital, Mubadala...
...40 Funds raised: About $300 million Investors: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala...
BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...University System. Undisclosed angel investors and all existing institutional investors, including Lux Capital, Data Collective, Mubadala...
BioCentury | Jul 13, 2019
Tools & Techniques

Broadening role for external control arms in clinical trials

...two-year old company has raised a $4.2 million seed round from DCVC Bio, Data Collective, Mubadala...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...a16z), Arch Venture Partners, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture Investments, Bezos Expeditions, Mubadala...
BioCentury | Apr 30, 2019
Finance

How Nextech-led round will help Vividion to POC

...helped found and launch J&J’s life science incubator JLABS. New investors BVF Partners, Casdin Capital, Mubadala...
BioCentury | Apr 16, 2019
Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

...a16z), Arch Venture Partners, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture Investments, Bezos Expeditions, Mubadala...
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital and Felicix, and new investors Mubadala...
Items per page:
1 - 10 of 11
BioCentury | Feb 25, 2021
Finance

$135M series C buys Vividion flexibility to explore broad pipeline

...Woodline Partners, Acuta Capital and Driehaus Capital Management, alongside existing investors BVF Partners, Casdin Capital, Mubadala...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...private placement in which it sold shares to Mubadala Investment Co. and Novo Holdings A/S. Mubadala...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...has raised $7.9 million in a seed round led by Horizons Ventures, with participation from Mubadala...
BioCentury | Jun 17, 2020
Emerging Company Profile

Lightspeed, Klausner back Stanford cell therapy spinout Orca in new $192M round

...investor also co-led the round. Other series D investors included 8VC, DCVC Bio, ND Capital, Mubadala...
...40 Funds raised: About $300 million Investors: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala...
BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...University System. Undisclosed angel investors and all existing institutional investors, including Lux Capital, Data Collective, Mubadala...
BioCentury | Jul 13, 2019
Tools & Techniques

Broadening role for external control arms in clinical trials

...two-year old company has raised a $4.2 million seed round from DCVC Bio, Data Collective, Mubadala...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...a16z), Arch Venture Partners, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture Investments, Bezos Expeditions, Mubadala...
BioCentury | Apr 30, 2019
Finance

How Nextech-led round will help Vividion to POC

...helped found and launch J&J’s life science incubator JLABS. New investors BVF Partners, Casdin Capital, Mubadala...
BioCentury | Apr 16, 2019
Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

...a16z), Arch Venture Partners, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture Investments, Bezos Expeditions, Mubadala...
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital and Felicix, and new investors Mubadala...
Items per page:
1 - 10 of 11